The groundbreaking therapy of this peptide represents a major advance in the handling of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide586489.dsiblogger.com/75139094/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment